“AI in Medicine”的搜索结果，显示 81-90 项，共有 5766 项

1. 心血管医学- 临床试验- 妙佑医疗国际

   The purpose of this study is to assess termination of atrial fibrillation (AF) following delivery of cold treatment to the oblique sinus using an experimental ...

2. 神经科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to develop an artificial intelligence (AI) system than can process MR images acquired using conventional ...

3. 临床试验- 检验医学与病理学- 妙佑医疗国际

   ... medical records now and in the future. The Biobank serves as a library for researchers; instead of having to look for volunteers for each new project ...

4. 神经科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to develop an artificial intelligence (AI) system than can process MR images acquired using conventional ...

5. 神经科- 临床试验- 妙佑医疗国际

   The purpose of this study is to develop an artificial intelligence (AI) ... treatment in adults with early stage but ... treatment in adults with early ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... treatment(s), such as surgery, chemotherapy, and/or radiation, and (ii) to collect information about patients, treatments, and the behavior of the ...

7. 职业医学- 医生 - 妙佑医疗国际

   Internist · Public Health and General Preventive Medicine Specialist.

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Everyone in this study will receive pirtobrutinib and venetoclax. Venetoclax is U.S. Food and Drug Administration (FDA) approved for the treatment of CLL and ...

9. Mayo Clinic in Arizona provides transplants for patients with lower MELD scores rapidly with encouraging outcomes - 妙佑医疗国际

   Transplant Medicine · Mayo Clinic in Arizona provides transplants for patients with lower MELD scores rapidly with encouraging outcomes · 一份馈赠，无穷力量——今天 ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    Everyone in this study will receive pirtobrutinib and venetoclax. Venetoclax is U.S. Food and Drug Administration (FDA) approved for the treatment of CLL and ...